当期报告
TC BioPharm(TCBP)05-30 04:15
$TC BioPharm(TCBP)$ 8-K Current report, item 3.01 Accession Number: 0001493152-24-021782 Act: 34 Size: 270 KB 网页链接
简介:TC BioPharm (Holdings) plc.是一家于2021年10月25日根据苏格兰法律注册成立的公司。TC BioPharm 是一家临床阶段的生物制药公司,专注于基于其专有的同种异体gamma delta T (GD-T)细胞平台开发新型免疫治疗产品。利用GD-T的先天能力,TCB能够开发一系列旨在对抗癌症和病毒感染的临床阶段细胞疗法。
今开:0.815 | 昨收:0.8189 |
最高:0.9 | 最低:0.815 |
涨停价: | 跌停价: |
总市值:7600619 |
TC BioPharm(TCBP)05-30 04:15
$TC BioPharm(TCBP)$ 8-K Current report, item 3.01 Accession Number: 0001493152-24-021782 Act: 34 Size: 270 KB 网页链接
TC BioPharm(TCBP)06-21 04:15
$TC BioPharm(TCBP)$ S-3/A [Amend] Registration statement under Securities Act of 1933 Accession Number: 0001493152-24-024499 Act: 33 Size: 1 MB 网页链接
TC BioPharm(TCBP)07-02 04:15
$TC BioPharm(TCBP)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-025790 Act: 34 Size: 673 KB 网页链接
TC BioPharm(TCBP)05-06 20:35
$TC BioPharm(TCBP)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001493152-24-017853 Act: 34 Size: 297 KB 网页链接
TC BioPharm(TCBP)06-29 04:35
$TC BioPharm(TCBP)$ 8-K Current report, item 5.02 Accession Number: 0001493152-24-025622 Act: 34 Size: 264 KB 网页链接
TC BioPharm(TCBP)06-25 18:05
$TC BioPharm(TCBP)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-001928 Act: 33 Size: 1 KB 网页链接
TC BioPharm(TCBP)04-30 05:25
$TC BioPharm(TCBP)$ 10-K/A [Amend] Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001493152-24-017053 Act: 34 Size: 11 MB 网页链接
TC BioPharm(TCBP)06-08 04:15
$TC BioPharm(TCBP)$ DEF 14A Other definitive proxy statements Accession Number: 0001493152-24-023099 Act: 34 Size: 2 MB 网页链接
TC BioPharm(TCBP)05-29 04:15
$TC BioPharm(TCBP)$ PRE 14A Other preliminary proxy statements Accession Number: 0001493152-24-021600 Act: 34 Size: 362 KB 网页链接
TC BioPharm(TCBP)06-27 04:15
$TC BioPharm(TCBP)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001493152-24-025262 Act: 33 Size: 914 KB 网页链接
丰硕创投04-17 17:47
$TC BioPharm(TCBP)$ 2024年1月3日,网页链接{TC BioPharm}公司宣布措施进行降本增效,该司是一家开发同种异体γ&δ T细胞的公司.查看全文
牛唐2022-03-18 11:15
医药板块速评(2022.03.17)
本期内容提示:
1、4月的AACR大会即将召开,众多药企有数据发布,哪些公司有配置机会?
2、$Eiger(EIGR)等疫情概念股又起行情,哪些公司还有类似机会?
3、$TC BioPharm(TCBP)$ 、$Revelation(REVB)等小市值公司暴涨,下一个机会在哪里?
$沃森...查看全文
韩信超短2022-03-18 00:02
$TC BioPharm(TCBP)$ 买买买啊!我睡了查看全文
韩信超短2022-03-18 00:02
$TC BioPharm(TCBP)$ 真的想搞事啊查看全文
$TC BioPharm(TCBP)$ F-1 Registration statement for certain foreign private issuers Accession Number: 0001493152-24-026004 Act: 33 Size: 1 MB 网页链接
$TC BioPharm(TCBP)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-025802 Act: 34 Size: 815 KB 网页链接
$TC BioPharm(TCBP)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001493152-24-025790 Act: 34 Size: 673 KB 网页链接
$TC BioPharm(TCBP)$ 8-K Current report, item 5.02 Accession Number: 0001493152-24-025622 Act: 34 Size: 264 KB 网页链接
$TC BioPharm(TCBP)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001493152-24-025262 Act: 33 Size: 914 KB 网页链接
$TC BioPharm(TCBP)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-001928 Act: 33 Size: 1 KB 网页链接
$TC BioPharm(TCBP)$ S-3/A [Amend] Registration statement under Securities Act of 1933 Accession Number: 0001493152-24-024499 Act: 33 Size: 1 MB 网页链接
$TC BioPharm(TCBP)$ DEF 14A Other definitive proxy statements Accession Number: 0001493152-24-023099 Act: 34 Size: 2 MB 网页链接
$TC BioPharm(TCBP)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001493152-24-022939 Act: 33 Size: 1 MB 网页链接
$TC BioPharm(TCBP)$ 8-K Current report, item 3.01 Accession Number: 0001493152-24-021782 Act: 34 Size: 270 KB 网页链接